Bill Text: FL S7050 | 2010 | Regular Session | Introduced
Bill Title: Blood Establishments
Spectrum: Unknown
Status: (N/A - Dead) 2010-02-03 - Submit as committee bill by Health Regulation (SB 1818) [S7050 Detail]
Download: Florida-2010-S7050-Introduced.html
Florida Senate - 2010 (PROPOSED COMMITTEE BILL) SPB 7050 FOR CONSIDERATION By the Committee on Health Regulation 588-01616A-10 20107050__ 1 A bill to be entitled 2 An act relating to blood establishments; amending s. 3 381.06014, F.S.; prohibiting local governments from 4 restricting access to public facilities or 5 infrastructure for certain activities based on whether 6 a blood establishment is operating as a for-profit 7 organization or not-for-profit organization; 8 prohibiting a blood establishment from considering 9 whether certain customers are operating as a for 10 profit organization or not-for-profit organization 11 when determining prices for selling blood or blood 12 components; amending s. 499.005, F.S.; clarifying 13 provisions prohibiting the unauthorized wholesale 14 distribution of a prescription drug that was purchased 15 by a hospital or other health care entity, to conform 16 to changes made by the act; amending s. 499.01, F.S.; 17 requiring certain blood establishments to obtain a 18 restricted prescription drug distributor permit under 19 specified conditions; providing an effective date. 20 21 Be It Enacted by the Legislature of the State of Florida: 22 23 Section 1. Subsections (5) and (6) are added to section 24 381.06014, Florida Statutes, to read: 25 381.06014 Blood establishments.— 26 (5) A local government may not restrict the access to or 27 use of any public facility or infrastructure for the collection 28 of blood or blood components from volunteer donors based on 29 whether the blood establishment is operating as a for-profit 30 organization or not-for-profit organization. 31 (6) In determining the price of blood or blood components 32 that are received from volunteer donors and sold to hospitals or 33 other health care providers, a blood establishment may not base 34 the price of the blood or blood component solely on whether the 35 purchasing entity is a for-profit organization or not-for-profit 36 organization. 37 Section 2. Subsection (21) of section 499.005, Florida 38 Statutes, is amended to read: 39 499.005 Prohibited acts.—It is unlawful for a person to 40 perform or cause the performance of any of the following acts in 41 this state: 42 (21) The wholesale distribution of any prescription drug 43 that was: 44 (a) Purchased by a public or private hospital or other 45 health care entity, except as authorized in s. 499.01(2)(g); or 46 (b) Donated or supplied at a reduced price to a charitable 47 organization. 48 Section 3. Paragraph (g) of subsection (2) of section 49 499.01, Florida Statutes, is amended to read: 50 499.01 Permits.— 51 (2) The following permits are established: 52 (g) Restricted prescription drug distributor permit.— 53 1. A restricted prescription drug distributor permit is 54 required for: 55 a. Any person that engages in the distribution of a 56 prescription drug, which distribution is not considered 57 “wholesale distribution” under s. 499.003(53)(a). 58 b.1.AnyAperson who engages in the receipt or 59 distribution of a prescription drug in this state for the 60 purpose of processing its return or its destructionmust obtain61a permit as a restricted prescription drug distributorif such 62 person is not the person initiating the return, the prescription 63 drug wholesale supplier of the person initiating the return, or 64 the manufacturer of the drug. 65 c. A blood establishment located in this state which 66 collects blood and blood components only from volunteer donors 67 and which engages in the wholesale distribution of a 68 prescription drug to a health care entity. The blood 69 establishment must operate in accordance with s. 381.06014. The 70 blood establishment shall distribute only: 71 (I) Prescription drugs indicated for a bleeding or clotting 72 disorder or anemia; 73 (II) Blood-collection containers approved under s. 505 of 74 the federal act; or 75 (III) Drugs that are blood derivatives, blood recombinants, 76 or synthetic forms of a blood derivative, 77 78 as long as all of the health care services that the blood 79 establishment provides are related to its activities as a 80 registered blood establishment or the health care services 81 consist of collecting, processing, storing, or administering 82 human hematopoietic stem cells or progenitor cells or performing 83 diagnostic testing of specimens if these specimens are tested 84 together with specimens undergoing routine donor testing. 85 2. Storage, handling, and recordkeeping of these 86 distributions by a person permitted as a restricted prescription 87 drug distributor must comply with the requirements for wholesale 88 distributors under s. 499.0121, but not those set forth in s. 89 499.01212 if the distribution occurs pursuant to sub 90 subparagraph 1.a. or sub-subparagraph 1.b. 91 3. A person who applies for a permit as a restricted 92 prescription drug distributor, or for the renewal of such a 93 permit, must provide to the department the information required 94 under s. 499.012. 95 4. The department may adopt rules regarding the 96 distribution of prescription drugs by hospitals, health care 97 entities, charitable organizations, or other persons not 98 involved in wholesale distribution, which rules are necessary 99 for the protection of the public health, safety, and welfare. 100 Section 4. This act shall take effect July 1, 2010.